MedTrace Logo

Pre-Surgery If Needed for Oesophageal Cancer

NCT03937362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-03-03

No results posted yet for this study

Summary

A prospective, multi-centre, diagnostic cohort study investigating the accuracy of positron emission tomography with computed tomography (PET-CT), endoscopic bite-on-bite biopsies and endoscopic ultrasonography (EUS) with fine-needle aspiration (FNA) for detecting residual disease after neoadjuvant chemoradiotherapy in patients with potentially resectable esophageal squamous cell carcinoma (SCC).

Conditions

  • Esophageal Cancer

Interventions

DIAGNOSTIC_TEST

First clinical response evaluation (CRE-1)

Consisting of: endoscopy with bite-on-bite biopsies

DIAGNOSTIC_TEST

Second clinical response evaluation (CRE-2)

Consisting of: PET-CT, endoscopic bite-on-bite biopsies,EUS with FNA

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Queen Mary Hospital, Hong Kong

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Zhigang Li, MD, PhD · Shanghai Chest Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2023-05-31
Completion
2024-05-31

Countries

  • China
  • Hong Kong
  • Netherlands
  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03937362 on ClinicalTrials.gov